Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergoogle.com
Google Alert - HER2-ADC
Get the latest updates from Google Alert - HER2-ADC directly as they happen.
Follow now 124 followers
Latest posts
Last updated about 16 hours ago
Multiomic Real-World Data Predict Outcomes in Metastatic Breast Cancer
about 19 hours ago
Multiomic profiling, including whole exome and transcriptome sequencing, offers prognostic value beyond...
HER2-Low Advances vs. Cost Barriers in Metastatic Breast Cancer Treatment - 조선일보
1 day ago
[How to Heal] ADC drugs like Enhertu improve survival, but high costs...
LigaChem Biosciences (141080 KQ/Buy)Clinical Data to Watch in 2026 - Smartkarma
1 day ago
We valued LCB14 (HER2-targeting ADC; regulatory filing in China expected in 2026)...
Preventing HER2 degradation improves efficacy of trastuzumab deruxtecan | Nature Cancer
2 days ago
The authors next showed that FBXL2 silencing rendered T-DXd-unresponsive HER2-0 cells sensitive...
The Evolution of ADC's: Q&A with Ethan Smith | PharmExec
3 days ago
You can use HER2 ADC after using a HER2 map, and that...
[JPM 2026] Samjin outlines shift from generics to new drug R&D | - KBR
3 days ago
... HER2 ADC treatment, compared with existing HER2-targeting ADCs. These results provide...
Alphamab's HER2 bispecific hits phase III gastric cancer endpoints | BioWorld
4 days ago
In China, anbenitamab could also be better positioned than ADCs when it...
Alphamab Oncology Announces the Results of a Phase III Clinical Study of Anbenitamab ...
4 days ago
Alphamab Oncology Announces Biparatopic HER2-targeting ADC JSKN003 Was Granted Breakthrough Therapy Designation...
Daiichi Sankyo navigates complexity of success as Enhertu, Datroway push for market dominance
5 days ago
Further consolidating its status as the leading HER2 ADC ... Complexity in...
映恩生物-B(9606.HK)事件点评：引领ADC迭代浪潮 2026年有望实现商业化 - Futubull
8 days ago
In China, the Phase III clinical trial of HER2 ADC DB-1303 for...
Bio-Thera Solutions identifies new HER2-targeted antibody-drug conjugates | BioWorld
8 days ago
An exemplified ADC (mAb1-ANK-GGFG pg 81, claim 16) displayed antiproliferative activity against...
Daiichi Sankyo & AstraZeneca's Enhertu approved in China as first and only HER2 directed ...
8 days ago
Daiichi Sankyo & AstraZeneca's Enhertu approved in China as first and only...